Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$0.41 - $0.88 $9,737 - $20,900
-23,750 Reduced 98.96%
250 $0
Q3 2021

Nov 04, 2021

BUY
$1.83 - $3.18 $43,920 - $76,320
24,000 New
24,000 $52,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $43.2M
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Close Asset Management LTD Portfolio

Follow Close Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.